These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 28534478)

  • 1. Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression.
    Rosenbluh J; Xu H; Harrington W; Gill S; Wang X; Vazquez F; Root DE; Tsherniak A; Hahn WC
    Nat Commun; 2017 May; 8():15403. PubMed ID: 28534478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.
    Iorio F; Behan FM; Gonçalves E; Bhosle SG; Chen E; Shepherd R; Beaver C; Ansari R; Pooley R; Wilkinson P; Harper S; Butler AP; Stronach EA; Saez-Rodriguez J; Yusa K; Garnett MJ
    BMC Genomics; 2018 Aug; 19(1):604. PubMed ID: 30103702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.
    Meyers RM; Bryan JG; McFarland JM; Weir BA; Sizemore AE; Xu H; Dharia NV; Montgomery PG; Cowley GS; Pantel S; Goodale A; Lee Y; Ali LD; Jiang G; Lubonja R; Harrington WF; Strickland M; Wu T; Hawes DC; Zhivich VA; Wyatt MR; Kalani Z; Chang JJ; Okamoto M; Stegmaier K; Golub TR; Boehm JS; Vazquez F; Root DE; Hahn WC; Tsherniak A
    Nat Genet; 2017 Dec; 49(12):1779-1784. PubMed ID: 29083409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
    Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
    Elife; 2020 May; 9():. PubMed ID: 32441252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speed genome editing by transient CRISPR/Cas9 targeting and large DNA fragment deletion.
    Luo J; Lu L; Gu Y; Huang R; Gui L; Li S; Qi X; Zheng W; Chao T; Zheng Q; Liang Y; Zhang L
    J Biotechnol; 2018 Sep; 281():11-20. PubMed ID: 29886029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells.
    Daer RM; Cutts JP; Brafman DA; Haynes KA
    ACS Synth Biol; 2017 Mar; 6(3):428-438. PubMed ID: 27783893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.
    Klann TS; Black JB; Chellappan M; Safi A; Song L; Hilton IB; Crawford GE; Reddy TE; Gersbach CA
    Nat Biotechnol; 2017 Jun; 35(6):561-568. PubMed ID: 28369033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A RecET-assisted CRISPR-Cas9 genome editing in Corynebacterium glutamicum.
    Wang B; Hu Q; Zhang Y; Shi R; Chai X; Liu Z; Shang X; Zhang Y; Wen T
    Microb Cell Fact; 2018 Apr; 17(1):63. PubMed ID: 29685154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
    He Z; Kee K
    Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes.
    Goyal A; Myacheva K; Groß M; Klingenberg M; Duran Arqué B; Diederichs S
    Nucleic Acids Res; 2017 Feb; 45(3):e12. PubMed ID: 28180319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
    Minkenberg B; Wheatley M; Yang Y
    Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 18. Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells.
    Zheng Q; Cai X; Tan MH; Schaffert S; Arnold CP; Gong X; Chen CZ; Huang S
    Biotechniques; 2014; 57(3):115-24. PubMed ID: 25209046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors.
    Rousset F; Cui L; Siouve E; Becavin C; Depardieu F; Bikard D
    PLoS Genet; 2018 Nov; 14(11):e1007749. PubMed ID: 30403660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class 2 CRISPR-Cas RNA-guided endonucleases: Swiss Army knives of genome editing.
    Stella S; Alcón P; Montoya G
    Nat Struct Mol Biol; 2017 Nov; 24(11):882-892. PubMed ID: 29035385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.